[go: up one dir, main page]

AR066245A1 - Composiciones de fibrina que contienen compuestos de estroncio - Google Patents

Composiciones de fibrina que contienen compuestos de estroncio

Info

Publication number
AR066245A1
AR066245A1 ARP080101685A ARP080101685A AR066245A1 AR 066245 A1 AR066245 A1 AR 066245A1 AR P080101685 A ARP080101685 A AR P080101685A AR P080101685 A ARP080101685 A AR P080101685A AR 066245 A1 AR066245 A1 AR 066245A1
Authority
AR
Argentina
Prior art keywords
compound
fibrine
compositions containing
containing strontium
composition
Prior art date
Application number
ARP080101685A
Other languages
English (en)
Inventor
Stephen E Terry
Gerald Zimmer
John J Barry
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of AR066245A1 publication Critical patent/AR066245A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/225—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/28—Bones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/446—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/502—Plasticizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Composite Materials (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Cell Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Botany (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una composicion para su uso en la cicatrizacion osea y la regeneracion osea en la forma de un gel tipo hidrogel viscoelástico o de una formulacion líquida que comprende fibrinogeno, trombina y un componente inorgánico que comprende un compuesto quecontiene estroncio (Sr) y/o posiblemente otro metal tal como un compuesto que contiene calcio. El compuesto que contiene estroncio se puede disolver en las soluciones de trombina o se puede agregar al coágulo en una forma cristalina particulada. Unavez mezclados los componentes, tiene lugar la gelificacion para formar una matriz. La composicion también puede comprender un compuesto que contiene iodo que actua como plastificador.
ARP080101685A 2007-04-23 2008-04-22 Composiciones de fibrina que contienen compuestos de estroncio AR066245A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92571607P 2007-04-23 2007-04-23

Publications (1)

Publication Number Publication Date
AR066245A1 true AR066245A1 (es) 2009-08-05

Family

ID=39745302

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080101685A AR066245A1 (es) 2007-04-23 2008-04-22 Composiciones de fibrina que contienen compuestos de estroncio

Country Status (16)

Country Link
US (1) US20080260714A1 (es)
EP (2) EP2142224B1 (es)
JP (2) JP5907656B2 (es)
KR (1) KR101520114B1 (es)
CN (2) CN103785058B (es)
AR (1) AR066245A1 (es)
AU (1) AU2008242867B2 (es)
BR (1) BRPI0811035B8 (es)
CA (1) CA2686820C (es)
CL (1) CL2008001171A1 (es)
CO (1) CO6251232A2 (es)
ES (2) ES2573327T3 (es)
IL (1) IL201480A0 (es)
MX (1) MX2009011268A (es)
TW (1) TWI556842B (es)
WO (1) WO2008131154A2 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1024250C2 (nl) * 2003-09-09 2005-03-10 Fluxxion B V Vervaardiging van een microzeef, en microzeef en inrichting met een microzeef.
CA2702190A1 (en) * 2007-10-12 2009-04-16 Kuros Biosurgery Ag Injectable radio-opaque compositions for tissue augmentation
ES2403057T3 (es) 2008-04-18 2013-05-13 Kuros Biosurgery Ag Dispositivo de suministro, kit que contiene el dispositivo, y método para operar el dispositivo
WO2010081037A1 (en) * 2009-01-08 2010-07-15 Numira Biosciences, Inc. Methods and compositions for imaging atherosclerotic plaques
WO2010081044A1 (en) * 2009-01-08 2010-07-15 Numira Biosciences, Inc. Methods and compositions for imaging cartilage and bone
JP5960051B2 (ja) * 2009-08-04 2016-08-02 プシロクス・エービーＰｓｉｌｏｘ ＡＢ イオン置換リン酸カルシウム粒子
US8882740B2 (en) * 2009-12-23 2014-11-11 Stryker Trauma Gmbh Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone
US8614190B2 (en) 2010-06-30 2013-12-24 Industrial Technology Research Institute Thermal responsive composition for treating bone diseases
WO2012024634A2 (en) * 2010-08-19 2012-02-23 University Of Washington Through Its Center For Commercialization Environmentally-responsive nanocomposites and methods of their use
JP5304939B1 (ja) * 2012-05-31 2013-10-02 大日本印刷株式会社 光学積層体、偏光板、偏光板の製造方法、画像表示装置、画像表示装置の製造方法及び画像表示装置の視認性改善方法
EP3122652A4 (en) * 2014-03-27 2017-12-13 Novabone Products, LLC Kit for delivering bone grafting materials
WO2015193836A1 (en) 2014-06-19 2015-12-23 Consiglio Nazionale Delle Ricerche (Cnr) Injectable apatitic cement ionically multi-substituted for regenerative vertebroplasty and kyphoplasty
US10238507B2 (en) 2015-01-12 2019-03-26 Surgentec, Llc Bone graft delivery system and method for using same
CN110198710A (zh) * 2016-12-09 2019-09-03 西北大学 骨促进性温敏大分子
US11116647B2 (en) 2018-04-13 2021-09-14 Surgentec, Llc Bone graft delivery system and method for using same
US10687828B2 (en) 2018-04-13 2020-06-23 Surgentec, Llc Bone graft delivery system and method for using same
WO2023129802A1 (en) 2021-12-30 2023-07-06 Baxter International Inc. Fibrinogen and thrombin solutions for a fibrin sealant and fibrin sealant kit
EP4467168A1 (en) * 2022-01-18 2024-11-27 Korea Institute of Science and Technology Apatite for filler and filler composition comprising same

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737411A (en) * 1986-11-25 1988-04-12 University Of Dayton Controlled pore size ceramics particularly for orthopaedic and dental applications
US4969888A (en) 1989-02-09 1990-11-13 Arie Scholten Surgical protocol for fixation of osteoporotic bone using inflatable device
IT1240938B (it) 1990-02-08 1993-12-27 S.E.I.P.I. Societa' Esportazione Importazione Prodotti Industriali Composizione vetrosa bioattiva per impianti ossei e prodotti ottenuti con tale composizione o che la comprendono
WO1991017777A2 (en) 1990-05-22 1991-11-28 University Of Florida Injectable bioactive glass compositions and methods for tissue reconstruction
JPH0662381B2 (ja) * 1990-06-26 1994-08-17 昭和薬品化工株式会社 骨性硬組織形成用ペースト組成物
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
FR2705235B1 (fr) * 1993-05-13 1995-07-13 Inoteb Utilisation de particules d'un sel de calcium biocompatible et biorésorbable comme ingrédient actif dans la préparation d'un médicament destiné au traitement local des maladies déminéralisantes de l'os.
US5549904A (en) * 1993-06-03 1996-08-27 Orthogene, Inc. Biological adhesive composition and method of promoting adhesion between tissue surfaces
US6248110B1 (en) 1994-01-26 2001-06-19 Kyphon, Inc. Systems and methods for treating fractured or diseased bone using expandable bodies
US6241734B1 (en) 1998-08-14 2001-06-05 Kyphon, Inc. Systems and methods for placing materials into bone
FI101129B (sv) 1995-01-13 1998-04-30 Vivoxid Oy Nya bioaktiva glas och deras användning
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
AU4456597A (en) * 1996-09-18 1998-04-14 Basf Aktiengesellschaft Pyridine derivatives, process for preparing the same and their use for controlling animal pests and harmful fungi
JPH10236976A (ja) * 1997-02-26 1998-09-08 Chemo Sero Therapeut Res Inst 骨形成促進剤
US20010016646A1 (en) * 1998-03-20 2001-08-23 David C. Rueger Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
FR2772746B1 (fr) * 1997-12-23 2000-01-28 Commissariat Energie Atomique Procede de fabrication d'une ceramique apatitique, en particulier pour usage biologique
ES2207258T3 (es) * 1998-07-13 2004-05-16 University Of Southern California Procedimiento para acelerar el crecimiento oseo y del cartilago y su recuperacion.
DE19956503A1 (de) * 1999-11-24 2001-06-21 Universitaetsklinikum Freiburg Spritzbares Knochenersatzmaterial
NO20014746D0 (no) * 2001-09-28 2001-09-28 Clas M Kjoelberg Smertelindrende middel
SE522098C2 (sv) 2001-12-20 2004-01-13 Bone Support Ab Ett nytt benmineralsubstitut
AU2003218271A1 (en) * 2002-04-18 2003-11-03 Carnegie Mellon University Method of manufacturing hydroxyapatite and uses therefor in delivery of nucleic acids
US7273523B2 (en) * 2002-06-07 2007-09-25 Kyphon Inc. Strontium-apatite-cement-preparations, cements formed therefrom, and uses thereof
DE10225420A1 (de) * 2002-06-07 2003-12-24 Sanatis Gmbh Strontium-Apatit-Zement-Zubereitungen, die daraus gebildeten Zemente und die Verwendung davon
ATE322295T1 (de) 2002-10-03 2006-04-15 Vivoxid Oy Bioaktive glaszusammensetzung
WO2004098619A2 (en) * 2003-05-07 2004-11-18 Osteologix A/S Treating cartilage / bone conditions with water-soluble strontium salts
US6905723B2 (en) 2003-05-30 2005-06-14 Depuy Products, Inc. Strontium-substituted apatite coating
KR100531922B1 (ko) * 2003-12-23 2005-11-29 주식회사 셀론텍 연골치료제 조성물 및 그 사용방법
US20080167513A1 (en) * 2004-02-26 2008-07-10 Osteologlx A/S Strontium-Containing Compounds for Use in the Prevention or Treatment of Necrotic Bone Conditions
FR2869544B1 (fr) * 2004-05-03 2006-07-21 Centre Nat Rech Scient Cnrse Composition pour ciment injectable, utile comme substitut osseux
CA2571449C (en) * 2004-06-25 2015-12-08 John Nikolaj Hvarre Christensen Compositions comprising strontium and vitamin d and uses thereof
EP1655042A1 (en) 2004-11-02 2006-05-10 Vivoxid Oy A medical device
EP1833522B1 (en) * 2005-01-06 2016-06-22 Kuros Biosurgery AG Supplemented matrices for the repair of bone fractures
US20060216321A1 (en) * 2005-03-24 2006-09-28 Sdgi Holdings, Inc. Solvent based processing technologies for making tissue/polymer composites
CN1846789A (zh) * 2005-04-14 2006-10-18 南方医院 一种注射型骨修复材料及其制备与应用
PL2021043T3 (pl) * 2006-05-26 2011-06-30 Baxter Int Wstrzykiwalny wypełniacz pustych przestrzeni w kościach
AU2007268175B2 (en) * 2006-05-26 2013-05-23 Baxter Healthcare S.A. Injectable fibrin composition for bone augmentation
DE602006011323D1 (de) * 2006-09-20 2010-02-04 Inion Oy Bioaktive Glaszusammensetzungen

Also Published As

Publication number Publication date
BRPI0811035B1 (pt) 2018-07-31
CN103785058A (zh) 2014-05-14
WO2008131154A3 (en) 2008-12-24
CA2686820C (en) 2016-06-28
EP2142224B1 (en) 2016-03-23
ES2594081T3 (es) 2016-12-15
EP2142224A2 (en) 2010-01-13
HK1205961A1 (en) 2015-12-31
US20080260714A1 (en) 2008-10-23
JP5907656B2 (ja) 2016-04-26
MX2009011268A (es) 2009-11-02
JP2010525070A (ja) 2010-07-22
CN101668549B (zh) 2014-04-09
KR20100017158A (ko) 2010-02-16
AU2008242867A1 (en) 2008-10-30
KR101520114B1 (ko) 2015-05-13
TWI556842B (zh) 2016-11-11
CN103785058B (zh) 2016-12-07
JP2013216678A (ja) 2013-10-24
IL201480A0 (en) 2010-05-31
JP6012551B2 (ja) 2016-10-25
CN101668549A (zh) 2010-03-10
BRPI0811035B8 (pt) 2021-05-25
ES2573327T3 (es) 2016-06-07
EP2823829A1 (en) 2015-01-14
EP2823829B1 (en) 2016-07-20
CA2686820A1 (en) 2008-10-30
CL2008001171A1 (es) 2008-11-03
WO2008131154A2 (en) 2008-10-30
BRPI0811035A2 (pt) 2014-10-21
AU2008242867B2 (en) 2014-01-23
CO6251232A2 (es) 2011-02-21
TW200902096A (en) 2009-01-16

Similar Documents

Publication Publication Date Title
AR066245A1 (es) Composiciones de fibrina que contienen compuestos de estroncio
MX353841B (es) Composiciones antimicrobianas y metodos de uso.
CO2018012181A2 (es) Compuestos arilo o heteroarilo sustituidos con amino como inhibidores de ehmt1 y ehmt2
AR047928A1 (es) Derivados de tetrahidropiridoindol
PE20090605A1 (es) Composiciones de fenilalanina amoniaco-liasa procariotica y metodos del tratamiento del cancer usando composiciones de la misma
CO6290631A2 (es) Composición oral que contiene amino ácidos y un agente blanqueador
ECSP088109A (es) Composición agrícola
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
PE20080523A1 (es) Composiciones farmaceuticas topicas que comprenden un modificador de respuesta inmune
BRPI0511478A (pt) composições de vidro como aditivo antimicrobiano para materiais dentários
CR20150523A (es) Uso de 2,3-dihidroimidazo [1,2-c]quinazolinas sustituidas
PA8509801A1 (es) Compuestos antibioticos de azalida
ATE403469T1 (de) Emboliezusammensetzungen enthaltend pyrogenes silicium
EA201001555A1 (ru) Антиоксидативные модуляторы воспаления: производные олеанолевой кислоты с аминовыми и другими модификациями на с-17
BRPI0515594B8 (pt) compostos inibidores da interação entre mdm2 e p53,composição farmacêutica, processo para a preparação desta composição farmacêutica, usos dos compostos, suas combinações e processo para a preparação destes compostos
ECSP12012353A (es) Compuestos, composiciones de tioacetato y métodos de uso
CO6290696A2 (es) Gel de fibrina para liberacion controlada de pdgf y usos del mismo
BR112012016633A2 (pt) composição farmacêutica em pó seco e método de tratamento de ferida.
BRPI0916286B8 (pt) amidofenóxi-indazóis úteis como inibidores de c-met, seus usos, e composição farmacêutica
UY33452A (es) Triazolopiridinas sustituidas
AR061034A1 (es) Alaninas sustituidas con benzoilo
UY29469A1 (es) Compuestos sulfoximino-macrocíclicos y sus sales, composiciones farmacéuticas que comprenden dichos compuestos, métodos de preparación y usos de los mismos.
PE20140621A1 (es) Mejoras en o relacionadas con composiciones cementicias
CL2009000084A1 (es) Compuestos derivados de sulfonamida sustituida, moduladores de receptores de bradiquinina; composicion farmaceutica que contiene a los compuestos; y uso en el tratamiento del dolor agudo, neuropatico o cronico, entre otros.
EA200970132A1 (ru) Аналоги морфолинила и пирролидинила

Legal Events

Date Code Title Description
FB Suspension of granting procedure